Cognitive consequences of regression of cerebral small vessel disease

Autor: Frank-Erik de Leeuw, Esther M.C. van Leijsen, Ingeborg W.M. van Uden, Sjacky Cooijmans, Anil M. Tuladhar, Mohsen Ghafoorian, Mayra I. Bergkamp, Helena M. van der Holst, David G. Norris, Roy P. C. Kessels, Bram Platel
Přispěvatelé: Neurology
Rok vydání: 2018
Předmět:
medicine.medical_specialty
Alzheimer`s disease Donders Center for Medical Neuroscience [Radboudumc 1]
Biophysics
Medizin
Disease
030204 cardiovascular system & hematology
150 000 MR Techniques in Brain Function
03 medical and health sciences
All institutes and research themes of the Radboud University Medical Center
0302 clinical medicine
Neuroimaging
Original Research Articles
Internal medicine
medicine
Cognitive decline
Neuro- en revalidatiepsychologie
medicine.diagnostic_test
business.industry
Data Science
Neuropsychology and rehabilitation psychology
Magnetic resonance imaging
Cognition
Disorders of movement Donders Center for Medical Neuroscience [Radboudumc 3]
Regression
Cardiology
Neurology (clinical)
Small vessel
Cardiology and Cardiovascular Medicine
business
030217 neurology & neurosurgery
Zdroj: European Stroke Journal, 4, 85-89
European Stroke Journal, 4, 1, pp. 85-89
van Leijsen, E M C, Bergkamp, M I, van Uden, I W M, Cooijmans, S, Ghafoorian, M, van der Holst, H M, Norris, D G, Kessels, R P C, Platel, B, Tuladhar, A M & de Leeuw, F-E 2019, ' Cognitive consequences of regression of cerebral small vessel disease ', European Stroke Journal, vol. 4, no. 1, pp. 85-89 . https://doi.org/10.1177/2396987318820790
European Stroke Journal, 4(1), 85-89. SAGE Publications Inc.
ISSN: 2396-9881
2396-9873
DOI: 10.1177/2396987318820790
Popis: Introduction Recent studies have shown that neuroimaging markers of cerebral small vessel disease can also regress over time. We investigated the cognitive consequences of regression of small vessel disease markers. Patients and methods Two hundred and seventy-six participants of the RUNDMC study underwent neuroimaging and cognitive assessments at three time-points over 8.7 years. We semi-automatically assessed white matter hyperintensities volumes and manually rated lacunes and microbleeds. We analysed differences in cognitive decline and accompanying brain atrophy between participants with regression, progression and stable small vessel disease by analysis of variance. Results Fifty-six participants (20.3%) showed regression of small vessel disease markers: 31 (11.2%) white matter hyperintensities regression, 10 (3.6%) vanishing lacunes and 27 (9.8%) vanishing microbleeds. Participants with regression showed a decline in overall cognition, memory, psychomotor speed and executive function similar to stable small vessel disease. Participants with small vessel disease progression showed more cognitive decline compared with stable small vessel disease (p Discussion Regression of small vessel disease markers was associated with similar cognitive decline compared to stable small vessel disease and did not accompany brain atrophy, suggesting that small vessel disease regression follows a relatively benign clinical course. Future studies are required to validate these findings and to assess the role of vascular risk factor control on small vessel disease regression and possible recovery of clinical symptoms. Conclusion Our findings of comparable cognitive decline between participants with regression and stable small vessel disease might suggest that small vessel disease regression has a relative benign cognitive outcome.
Databáze: OpenAIRE